0001209191-17-031852.txt : 20170512
0001209191-17-031852.hdr.sgml : 20170512
20170512152410
ACCESSION NUMBER: 0001209191-17-031852
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170512
FILED AS OF DATE: 20170512
DATE AS OF CHANGE: 20170512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCMANUS MICHAEL A JR
CENTRAL INDEX KEY: 0001051997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 17838217
MAIL ADDRESS:
STREET 1: 241-02 NORTHERN BLVD
CITY: DOUGLASTON
STATE: NY
ZIP: 11362
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-12
0
0001000694
NOVAVAX INC
NVAX
0001051997
MCMANUS MICHAEL A JR
C/O NOVAVAX, INC.
20 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Common Stock
2017-05-12
4
P
0
20000
0.9698
A
277590
D
The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9696 to $0.97, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
/s/ John A. Herrmann III, Attorney-in-Fact
2017-05-12